OPALGENIX

Our technology incorporates precision genotyping to identify genetic variations in a patient sample coupled with intelligent analytics to inform personalized opioid selection to maximize surgical pain relief while minimizing opioid-related patient safety risks with greater than 80% sensitivity and specificity.

Also known as: OpalGenix, Inc

Primary location: Indianapolis United States